Expansion of TAVR into Low-Risk Patients and Who to Consider for SAVR

Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of severe aortic stenosis (AS) over the last decade. The results of the Placement of Aortic Transcatheter Valves (PARTNER) 3 and Evolut Low Risk trials demonstrated the safety and efficacy of TAVR in low-surgical-risk pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Kunal V., Omar, Wally, Gonzalez, Pedro Engel, Jessen, Michael E., Huffman, Lynn, Kumbhani, Dharam J., Bavry, Anthony A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584721/
https://www.ncbi.nlm.nih.gov/pubmed/32875469
http://dx.doi.org/10.1007/s40119-020-00198-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584721/
https://www.ncbi.nlm.nih.gov/pubmed/32875469
http://dx.doi.org/10.1007/s40119-020-00198-z

Ejemplares similares